Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
17.43 USD | +0.46% | +1.57% | +0.35% |
02-23 | Oppenheimer Adjusts Crescent Capital BDC Price Target to $19 From $18, Maintains Outperform Rating | MT |
02-22 | Transcript : Crescent Capital BDC, Inc., Q4 2023 Earnings Call, Feb 22, 2024 |
Strengths
- The group's activity appears highly profitable thanks to its outperforming net margins.
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- This company will be of major interest to investors in search of a high dividend stock.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company's earnings growth outlook lacks momentum and is a weakness.
- Revenue estimates are regularly revised downwards for the current and coming years.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Sector: Closed End Funds
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+0.35% | 643M | - | ||
+4.09% | 12.61B | C | ||
+6.57% | 9.01B | - | C- | |
-3.63% | 5.41B | D+ | ||
+3.33% | 5.25B | - | D | |
+5.68% | 5.19B | - | - | |
+14.98% | 4.48B | - | - | |
+16.71% | 4.44B | - | - | |
+1.53% | 4B | - | ||
+3.73% | 3.75B | - | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- CCAP Stock
- Ratings Crescent Capital BDC, Inc.